It may be hypothesized that the active oxidative metabolism in such melanoma cells, presumably less dependent on glucose than glycolytic melanomas, might reduce nutrient competition with the T lymphocytes, eventually leading to higher antigen presentation and IFN signaling in the responding patients, making these tumors vulnerable to T-cell cytotoxic activity [39]. The gene discussed is IFNA1; the disease is melanoma.